CHEK2 and breast carcinoma: Aloraifi and colleagues performed a meta-analysis of protein-truncating variants in moderate-risk breast cancer genes in 2015 and cited only 12 out of 54 published CHEK2 analyses (22%) that had performed full gene scanning [113].